Alex Badamchi-Zadeh

Vice President, Therapeutics atSV Health InvestorsUK

Alex Badamchi-Zadeh is Vice President of Therapeutics at SV Health Investors. He was promoted to this role in 2024 following the EyeBio exit, recognizing his contribution as a key member of the SV deal team.

What Alex can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Also at SV Health Investors

Partners like Alex

At firms with a similar stage, sector and check size.

Alert me when SV Health Investors is active

One email when Alex's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Alex Badamchi-Zadeh?

Alex Badamchi-Zadeh is Vice President of Therapeutics at SV Health Investors. He was promoted to this role in 2024 following the EyeBio exit, recognizing his contribution as a key member of the SV deal team.

How much does Alex Badamchi-Zadeh invest?

SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Alex Badamchi-Zadeh?

A warm intro from a founder SV Health Investors backed works best.

Last updated 2026-10-15. Is this you? Ask for a correction.